Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
2 Jun, 2017 | 18:40h | UTCSofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: When DAA Treatment for Hepatitis C Fails, 3-Drug Regimen “Highly Effective” – Physician’s First Watch (free)